Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01367002
Title Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

endometrial serous adenocarcinoma

Therapies

Trastuzumab

Carboplatin + Paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
John Muir Clinical Research Center Concord California 94520 United States Details
Penrose St. Francis Hospital Colorado Springs Colorado 80907 United States Details
The Hospital of Central Connecticut New Britain Connecticut 06050 United States Details
Smilow Cancer Hospital at Yale New Haven New Haven Connecticut 06510 United States Details
Greater Baltimore Medical Center Baltimore Maryland 21204 United States Details
Walter Reed National Military Medical Center Bethesda Maryland 20889-5600 United States Details
University of Maryland Medical Center Silver Spring Maryland 20910 United States Details
Jersey Shore University Medical Center Neptune New Jersey 07753 United States Details
Montefiore Medical Center Bronx New York 10461 United States Details
Duke University School of Medicine Durham North Carolina 27710 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
The Ohio State University Hilliard Ohio 43026 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field